Karnataka HC: A Neighbour Cannot be Charged With Matrimonial Cruelty under Section 498A IPC  ||  Revisional Power U/S 25B(8) of Delhi Rent Control Act is Supervisory; HC Cannot Revisit Facts  ||  Poverty Cannot Bar Parole; Rajasthan HC Waives Surety For Indigent Life Convict, Sets Guidelines  ||  Delhi High Court: Late Payment of TDS Does Not Absolve Criminal Liability under the Income Tax Act  ||  NCLT Kochi: Avoidance Provisions under Insolvency Code Aim to Restore, Not Punish, Parties  ||  Bombay High Court: In IBC Cases, High Courts Lack Parallel Contempt Jurisdiction over the NCLT  ||  Supreme Court: Concluded Auction Cannot Be Cancelled Merely To Invite Higher Bids at a Later Stage  ||  SC: In Customs Classification, Statutory Tariff Headings and HSN Notes Prevail over Common Parlance  ||  SC: Under the Urban Land Ceiling Act, Notice U/S 10(5) Must be Served on the Person in Possession  ||  Supreme Court: Only Courts May Condone Delay; Tribunals Lack Power Unless Statute Allows    

Patent Office Rejects AcelRX's Application for Nanotab Sufentanil - (18 Sep 2015)

Indian Patent Office has refused patent application of US-based AcelRx Pharmaceuticals, Inc, for a nanotab sufentanil,which is supposed to be administered below tongue rather than swallowing a larger pill for relief. Application failed to pass the test of Section 3(d) of Patent Act.

Tags : INDIAN PATENT OFFICE  ACELRX  NANOTAB SUFENTANIL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved